Glipizide ER (extended release) is a medication used to treat type 2 diabetes. It is a sulfonylurea drug, which works by stimulating the pancreas to produce more insulin. It is a long-acting form of glipizide, which is a generic drug. Glipizide ER is a once-daily medication that helps to control blood sugar levels. It is often used in combination with other diabetes medications, such as metformin or insulin. The aim of this article is to provide a comprehensive review of glipizide ER, including its effectiveness, side effects, and safety.
Glipizide ER is an extended-release form of glipizide, a generic drug. It works by stimulating the pancreas to produce more insulin. Insulin is a hormone that helps the body use glucose from carbohydrates in the food we eat for energy or to store glucose for future use. Glipizide ER is usually taken once daily, usually in the morning. It is usually taken with food to reduce the risk of low blood sugar.
Studies have shown that glipizide ER is effective in controlling blood sugar levels in people with type 2 diabetes. In a 12-week study of over 400 people with type 2 diabetes, glipizide ER was found to be more effective than placebo in reducing fasting blood glucose levels. In another study of over 500 people with type 2 diabetes, glipizide ER was found to be more effective than placebo in reducing HbA1c levels.
Like all medications, glipizide ER can cause side effects. Common side effects include nausea, headache, dizziness, and diarrhea. Less common side effects include skin rash, weight gain, and abdominal pain. Rare side effects include low blood sugar (hypoglycemia) and an allergic reaction.
Glipizide ER is generally safe when taken as directed. It is important to follow the instructions of your healthcare provider when taking this medication. It is also important to monitor your blood sugar levels regularly and to report any changes to your healthcare provider.
In conclusion, glipizide ER is an effective medication for controlling blood sugar levels in people with type 2 diabetes. It is usually taken once daily and is usually taken with food to reduce the risk of low blood sugar. Common side effects include nausea, headache, dizziness, and diarrhea. It is important to follow the instructions of your healthcare provider and to monitor your blood sugar levels regularly.
1.
Belgian Algorithm Reshapes Endometrial Cancer Care
2.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
3.
Nuclear missile workers are contracting cancer: They blame the bases
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology
1.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
2.
Consensus Recommendations for Healthy Hematologic Aging
3.
The Role of Alanine Aminotransferase in Liver Health and Disease
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation